tiprankstipranks

Brian Concannon Insider Profile

4 Followers
Brian Concannon, President & CEO, Director at Haemonetics, holds 9.34K shares in Conmed (Ticker: CNMD), holds 147.04K shares in Haemonetics (Ticker: HAE). Most recently, Brian Concannon Sold ― shares of Conmed on Jun 08, 2023 for an estimated value of 104.76K.
tipranks
Brian Concannon

Brian Concannon
Haemonetics (HAE)
President & CEO, Director

Ranked #30,700 out of 98,909 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+14.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$15M
95.49%
4.51%
A breakdown of Brian Concannon's holdings

Insider Roles

Haemonetics
(HAE)
President & CEO, Director
Conmed
(CNMD)
Director
Roles that Brian Concannon holds in companies

Most Profitable Insider Trade

Stock:
Conmed
(CNMD)
Rating:Informative Sell
Date:Jun 08, 2023 - Today
Return:+45.50%
The most profitable trade made by Brian Concannon

Brian Concannon's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Haemonetics
Sep 16, 2015
President & CEO, Director
Uninformative Sell
230.90K
$14.32M
Conmed
Jun 08, 2023
Director
Informative Sell
104.76K
$676.51K
List of latest transactions for each holding click on a transaction to see Brian Concannon's performance on stock

Brian Concannon insider profile FAQ

What is the percentage of profitable transactions made by Brian Concannon?
The percentage of profitable transactions made by Brian Concannon is 67%.
    What is the average return per transaction made by Brian Concannon?
    The average return per transaction made by Brian Concannon is 14.60%.
      What stocks does Brian Concannon hold?
      Brian Concannon holds: HAE, CNMD stocks.
        What was Brian Concannon’s latest transaction?
        Brian Concannon latest transaction was an Informative Sell of $104.76K.
          What was Brian Concannon's most profitable transaction?
          Brian Concannon’s most profitable transaction was an Informative Sell of CNMD stock on June 8, 2023. The return on the trade was 45.50%.
            What is Brian Concannon's role in Haemonetics?
            Brian Concannon's role in Haemonetics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.